Patton Albertson Miller Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $218K | Sell |
9,060
-156
| -2% | -$4.08K | 0.02% | 206 |
|
|
2026
Q1 | $259K | Sell |
9,216
-8,909
| -49% | -$237K | 0.03% | 193 |
|
|
2025
Q4 | $451K | Sell |
18,125
-6,889
| -28% | -$174K | 0.05% | 164 |
|
|
2025
Q3 | $637K | Buy |
25,014
+3,442
| +16% | +$85K | 0.08% | 138 |
|
|
2025
Q2 | $523K | Sell |
21,572
-215
| -1% | -$5.01K | 0.07% | 150 |
|
|
2025
Q1 | $552K | Buy |
21,787
+1,199
| +6% | +$31.4K | 0.08% | 144 |
|
|
2024
Q4 | $546K | Sell |
20,588
-3,896
| -16% | -$106K | 0.07% | 143 |
|
|
2024
Q3 | $709K | Sell |
24,484
-759
| -3% | -$22.1K | 0.1% | 130 |
|
|
2024
Q2 | $706K | Sell |
25,243
-101,985
| -80% | -$2.81M | 0.1% | 125 |
|
|
2024
Q1 | $3.53M | Buy |
127,228
+23,035
| +22% | +$639K | 0.53% | 71 |
|
|
2023
Q4 | $3M | Sell |
104,193
-32,807
| -24% | -$992K | 0.5% | 75 |
|
|
2023
Q3 | $4.54M | Sell |
137,000
-1,089
| -0.8% | -$38.5K | 0.89% | 35 |
|
|
2023
Q2 | $5.07M | Sell |
138,089
-5,227
| -4% | -$203K | 0.98% | 28 |
|
|
2023
Q1 | $5.85M | Buy |
143,316
+2,759
| +2% | +$119K | 1.07% | 23 |
|
|
2022
Q4 | $7.2M | Sell |
140,557
-2,452
| -2% | -$118K | 1.32% | 14 |
|
|
2022
Q3 | $6.26M | Buy |
143,009
+1,733
| +1% | +$84.2K | 1.35% | 13 |
|
|
2022
Q2 | $7.41M | Sell |
141,276
-1,575
| -1% | -$80.3K | 1.51% | 9 |
|
|
2022
Q1 | $7.39M | Sell |
142,851
-5,055
| -3% | -$262K | 1.27% | 13 |
|
|
2021
Q4 | $8.73M | Buy |
147,906
+13,257
| +10% | +$657K | 1.41% | 11 |
|
|
2021
Q3 | $5.79M | Buy |
134,649
+27,253
| +25% | +$1.21M | 1.11% | 17 |
|
|
2021
Q2 | $4.21M | Buy |
107,396
+1,185
| +1% | +$46.1K | 0.96% | 24 |
|
|
2021
Q1 | $3.85M | Buy |
106,211
+102
| +0.1% | +$3.62K | 0.93% | 28 |
|
|
2020
Q4 | $3.68M | Sell |
106,109
-5,949
| -5% | -$218K | 0.87% | 28 |
|
|
2020
Q3 | $3.9M | Buy |
112,058
+1,150
| +1% | +$40.3K | 1.11% | 18 |
|
|
2020
Q2 | $3.44M | Buy |
110,908
+3,920
| +4% | +$133K | 1% | 19 |
|
|
2020
Q1 | $3.31M | Buy |
106,988
+3,989
| +4% | +$136K | 1.12% | 19 |
|
|
2019
Q4 | $3.83M | Buy |
102,999
+7,970
| +8% | +$284K | 1% | 19 |
|
|
2019
Q3 | $3.24M | Buy |
95,029
+4,648
| +5% | +$169K | 0.92% | 21 |
|
|
2019
Q2 | $3.12M | Buy |
90,381
+65,191
| +259% | +$2.59M | 0.9% | 23 |
|
|
2019
Q1 | $1.01M | Buy |
25,190
+9,944
| +65% | +$398K | 0.51% | 64 |
|
|
2018
Q4 | $603K | Buy |
15,246
+8,780
| +136% | +$364K | 0.32% | 76 |
|
|
2018
Q3 | $261K | Buy |
6,466
+588
| +10% | +$22.6K | 0.13% | 113 |
|
|
2018
Q2 | $202K | Buy |
+5,878
| New | +$201K | 0.1% | 114 |
|
|
2017
Q4 | – | Sell |
-6,932
| Closed | -$237K | – | 129 |
|
|
2017
Q3 | $237K | Sell |
6,932
-135
| -2% | -$4.34K | 0.1% | 117 |
|
|
2017
Q2 | $222K | Buy |
7,067
+177
| +3% | +$5.58K | 0.1% | 122 |
|
|
2017
Q1 | $218K | Buy |
+6,890
| New | +$217K | 0.09% | 130 |
|
|
2016
Q1 | – | Sell |
-7,474
| Closed | -$229K | – | 125 |
|
|
2015
Q4 | $229K | Sell |
7,474
-1,123
| -13% | -$35.3K | 0.12% | 116 |
|
|
2015
Q3 | $254K | Sell |
8,597
-1,627
| -16% | -$52.2K | 0.13% | 109 |
|
|
2015
Q2 | $325K | Sell |
10,224
-5,474
| -35% | -$178K | 0.14% | 112 |
|
|
2015
Q1 | $518K | Sell |
15,698
-584
| -4% | -$18.6K | 0.21% | 106 |
|
|
2014
Q4 | $481K | Sell |
16,282
-521
| -3% | -$14.9K | 0.22% | 111 |
|
|
2014
Q3 | $474K | Sell |
16,803
-24,288
| -59% | -$682K | 0.25% | 113 |
|
|
2014
Q2 | $1.16M | Sell |
41,091
-5,938
| -13% | -$169K | 0.59% | 54 |
|
|
2014
Q1 | $1.43M | Sell |
47,029
-5,207
| -10% | -$155K | 0.76% | 43 |
|
|
2013
Q4 | $1.52M | Buy |
52,236
+120
| +0.2% | +$3.49K | 0.89% | 40 |
|
|
2013
Q3 | $1.42M | Buy |
52,116
+5,846
| +13% | +$159K | 0.84% | 43 |
|
|
2013
Q2 | $1.23M | Buy |
+46,270
| New | +$1.28M | 0.74% | 49 |
|
Other funds holding PFE
Patton Albertson Miller Group's PFE Position: Q2 2026 in Review
Patton Albertson Miller Group reduced its Pfizer (PFE) stake by 1.7% in Q2 2026, selling an estimated $4.08K and leaving 9,060 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #206.
Patton Albertson Miller Group first reported a position in PFE in Q2 2013 and has held it in 47 quarters since. The position peaked at $8.73M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Patton Albertson Miller Group held 9,060 shares of Pfizer worth $218K as of Q2 2026.
- Patton Albertson Miller Group sold 156 Pfizer shares in Q2 2026, an estimated $4.08K.
- Pfizer made up 0.02% of Patton Albertson Miller Group's portfolio in Q2 2026, its #206 holding.
- Patton Albertson Miller Group first reported a position in Pfizer in Q2 2013 and has held it in 47 quarters since.
- Patton Albertson Miller Group's Pfizer position peaked at $8.73M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.